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Abstract
Background: Four-stranded G-quadruplexes (G4s) are DNA secondary structures in
the human genome that are primarily found in active promoters associated with
elevated transcription. Here, we explore the relationship between the folding of
promoter G4s, transcription and chromatin state.
Results: Transcriptional inhibition by DRB or by triptolide reveals that promoter G4
formation, as assessed by G4 ChIP-seq, does not depend on transcriptional activity.
We then show that chromatin compaction can lead to loss of promoter G4s and
is accompanied by a corresponding loss of RNA polymerase II (Pol II),
thus establishing a link between G4 formation and chromatin accessibility.
Furthermore, pre-treatment of cells with a G4-stabilising ligand mitigates the loss of
Pol II at promoters induced by chromatin compaction.
Conclusions: Overall, our findings show that G4 folding is coupled to the
establishment of accessible chromatin and does not require active transcription.
Keywords: G-quadruplexes, Transcription, RNA polymerase II, Chromatin compaction
Background
Four-stranded G-quadruplex (G4) structures form in DNA from stacked tetrads of
Hoogsteen-bonded guanines [1]. G4 sequence motifs are prevalent at promoters in the
human genome [2–4], and ChIP-sequencing using a G4 structure-specific antibody has
revealed that endogenous G4s are enriched in nucleosome-depleted regions (NDRs)
upstream of transcription start sites (TSSs) [5]. Genes marked by endogenous pro-
moter G4s in chromatin show higher transcriptional output than their non-G4 coun-
terparts [5]. Chromatin relaxation by histone deacetylase inhibitors can also lead to an
increase in G4 formation [5]. In patient-derived aggressive breast cancer, promoters of
highly amplified genes that show increased expression also exhibit increased G4 forma-
tion in chromatin [6]. As more than 99% of endogenous G4s overlap with transcription
factor (TF) binding sites [7], it is possible that such elevated gene expression results
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from increased TF occupancy at promoter G4s and the recruitment of RNA Pol II. The
observation that several TFs display high-affinity binding for G4s in vitro, including
SP1 [8], CNBP [9], and LARK [10], lends support to this. Alternatively, TF recruitment
to G4s could enhance transcription by unfolding the G4 structure, as has been sug-
gested for CNBP [11]. On the other hand, torsional stress and negative superhelicity
have been proposed to stimulate G4 formation at promoters as a consequence of active
transcription [12].
A central unanswered question is whether G4 formation at promoters of active genes
is a cause or a consequence of increased transcriptional activity. Herein, we establish
that the folding of G4s in promoters does not necessarily require active transcription
but can be favoured by an accessible chromatin state. Moreover, we provide evidence
that G4s are a genomic feature that enables the recruitment of Pol II to promoters.
Results
G4 structures mark promoters with increased Pol II occupancy
To investigate whether the process of transcription modulates G4 structure formation in
chromatin, we used the extensively characterised K562 human chronic myelogenous leu-
kaemia cell line as a model system [13]. G4 structure formation was determined by G4
ChIP-seq [14], chromatin accessibility by ATAC-seq (assay for transposase-accessible
chromatin using sequencing) and Pol II occupancy by Pol II ChIP-seq (Fig. 1a). Consensus,
endogenous G4s were defined as G4 ChIP-seq peaks present in at least two out of three
biological replicates (Pearson’s correlation R > 0.96). The majority of the consensus G4
peaks (> 75%) comprise G4 sequence motifs that have been independently shown to fold
into a G4 structure in vitro, by a DNA polymerase stalling assay (G4-seq; Additional file 1:
Fig. S1A) [15]. In K562 cells, consensus G4s were highly enriched in promoters (defined as
TSS ± 500 bp; Additional file 1: Fig. S1B), hereafter referred to as promoter G4s. Promoter
G4s marked genes with significantly increased expression compared to promoters lacking
a G4 structure (p < 2.2 × 10− 16; Additional file 1: Fig. S1C; RNA-seq dataset GEO accession
no. GSE88473). ATAC-seq on three independent biological replicates (Pearson’s correl-
ation R > 0.98) further revealed that the majority of all consensus G4s (88.2%) were located
in NDRs (Additional file 1: Fig. S1D) as exemplified by MYC and KRAS promoter G4s
(Fig. 1b). These results corroborate our previous observations, in HaCaT cells and primary
keratinocytes [5] and support that endogenous G4s are primarily found within open chro-
matin at promoters. Given that endogenous promoter G4s mark elevated transcription, as
a first step, we determined Pol II occupancy at such genes. Using Pol II ChIP-sequencing
(5 biological replicates; Pearson’s correlation R > 0.99), we observed significantly higher Pol
II occupancy at promoters with an endogenous G4 compared to those without (p < 2.2 ×
10− 16; Fig. 1c). To elucidate how G4 formation may be influenced by active transcription
and whether G4 formation is promoted by a more open versus compacted chromatin en-
vironment, we have focused the majority of the following studies exclusively on promoter
G4s (TSS ± 500 bp) occupied by Pol II.
Promoter G4 formation does not require active transcription
We directly evaluated whether active transcription is required for the formation of pro-
moter G4s, as has been suggested [12, 16], by measuring whether inhibition of
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transcription causes loss of G4s (Fig. 1d). To inhibit transcription elongation, K562 cells
were treated with the CDK9 inhibitor 5,6-dichlorobenzimidazole 1-β-D-ribofuranoside
(DRB) to prevent paused Pol II release [17, 18]. DRB treatment (1 h) decreased phos-
phorylation of Pol II at serine 2 with no effect on overall Pol II levels, as seen by West-
ern blotting (Fig. 1e), confirming the expected inhibitory mechanism. The DRB-treated
cells and DMSO-treated controls were subjected to G4 ChIP-seq. Promoter G4s in
DRB- versus DMSO-treated cells did not show statistically significant changes, in the
G4 ChIP-signal at the majority of sites (p < 0.01; 5/4023, 0.1% up, 136/4023, 3.4% down;
Fig. 1f). Thus, inhibition of Pol II-dependent elongation does not lead to loss of G4 for-
mation at promoters, rather G4 folding at promoters must precede productive tran-
scription elongation.
Fig. 1 Transcription is not necessary for G4 formation in promoters. a Experimental design overview. Black,
data generated in this study; blue, published RNA-seq datasets. b Representative examples of G4 ChIP-seq
genomic tracks in K562 cells for MYC and KRAS. From top to bottom tracks show G4 ChIP-seq signal
(yellow), G4 ChIP-seq input control (yellow), ATAC-seq signal (green) and sequence motifs that can form
G4s in vitro (defined as G4-seq sites, see ref [15]) on the forward (+ss) or reverse (−ss) strand (blue). The
signal is quantified as count per million (CPM). c Box plot of Pol II ChIP-seq signal (log2CPM) at promoters
(TSS ± 500 bp) in accessible chromatin (ATAC +) with an endogenous G4 (G4 ChIP +) or without a G4 (G4
ChIP−) but having sequence motifs that can fold into G4 structures in vitro (G4-seq). Wilcoxon-test: p <
2.2 × 10− 16. d Graphical representation of G4 formation and transcriptional inhibition experiments. e
Western blotting for Pol II Ser2-P and total Pol II from K562 cells treated with or without 100 μM DRB for 1
h. ß-actin provides the loading control. f Bland Altman (MA) plot showing the fold change in G4 ChIP-seq
signal at promoters between DRB-treated versus DMSO-treated K562 cells. Statistically significant (p < 0.01)
higher and lower signals are in red and blue, respectively; black dots indicate regions not changing. g
Western blotting for Pol II Ser5-P and total Pol II for K562 cells treated with or without 10 μM triptolide (TPL)
for 30 min or 2 h. ß-actin provides the loading control. h MA plot similar to panel F illustrating the fold
change in G4 ChIP-seq signal at promoters between TPL-treated versus untreated K562 cells (p < 0.01)
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To evaluate whether inhibition of transcription initiation causes loss of promoter
G4s, we used triptolide (TPL), which covalently inhibits the Pol II-associated helicase
XPB [19]. As seen by Western blotting, 2 h TPL treatment leads to substantial loss of
Pol II serine 5 phosphorylation and an overall loss of Pol II protein levels (Fig. 1g).
However, TPL inhibition did not significantly decrease the overall promoter G4-ChIP
signal (p < 0.01; 11/4268 down, 0.3%; Fig. 1h). Conversely, a significant number (p <
0.01; 449/4268 up, 10.5%) of promoter G4s showed increased G4 signal after TPL treat-
ment. This contrasts with experiments in human adenocarcinoma cells that showed no
G4 alterations following TPL treatment [20]. Our observation of increased G4 forma-
tion at promoters following TPL treatment is likely to arise from the abrogation of the
helicase activity of the G4-resolving helicases XPB/XPD [19, 21]. In contrast to earlier
work suggesting that G4 folding is promoted by active transcription through the gener-
ation of single-stranded DNA [12], our results suggest that active transcription is not
necessary for the folding of G4s in promoters.
Endogenous promoter G4 folding is sensitive to chromatin compaction
Given transcriptional inhibition does not remove promoter G4s in chromatin, and since
chromatin relaxation by histone deacetylase inhibition can increase their formation [5],
we hypothesised that the chromatin state may regulate promoter G4 formation. To
explore this, we used hypoxia to manipulate the chromatin state (Fig. 2a). Hypoxia in-
duces global chromatin compaction [22, 23] characterised by increased heterochroma-
tin protein HP1BP3 expression [24], elevated histone H3 lysine 9 methylation
(H3K9me3) [25] and reduced histone acetylation [26]. K562 cells were exposed to acute
hypoxic conditions (1% oxygen, 1 h). Hypoxia was confirmed by Western blotting for
hypoxia-inducible factor 1α induction [27] (Fig. 2b). Genome-wide chromatin compac-
tion upon hypoxia was then demonstrated by decreased sensitivity to micrococcal nu-
clease digestion [28] (Additional file 1: Fig. S2A). Moreover, in hypoxic chromatin,
ATAC-seq showed increased fragment sizes consistent with chromatin compaction
(Additional file 1: Fig. S2B). Additional validation of hypoxia induction was given by de-
creased Pol II occupancy seen at genes known to have reduced expression in hypoxic
K562 cells [29] (Additional file 1: Fig. S2C).
We first determined the chromatin status of active gene promoters in normoxia (21%
O2) by ATAC-seq and found that G4-marked promoters (i.e. Pol II
+ G4+) are located
in more accessible chromatin compared to their active non-G4-marked (i.e. Pol II+
G4−) counterparts (Fig. 2c). The induction of hypoxia then resulted in a significant re-
duction in ATAC-seq signal intensity at the majority of G4 promoter sites (p < 0.05;
7920/9217 down, 85.9%; Fig. 2d). In comparison, non-G4-marked promoters show
much less chromatin compaction (Additional file 1: Fig. S2D). After induction of hyp-
oxia, about a fifth of the promoter G4s showed a statistically significant decrease in sig-
nal intensity (p < 0.05; 1105/5558 down, 19.9%; Fig. 2e), which indicates that many
promoter G4s are sensitive to chromatin compaction. We next validated the general
principle of G4 loss upon hypoxia-associated chromatin compaction by using an add-
itional unrelated cell line. Acute hypoxia in human osteosarcoma U2OS cells also in-
duced chromatin compaction and led to a reduction of G4 signal intensity at
promoters (p < 0.05; 6150/8505 down, 72.3%; Additional file 1: Fig. S3).
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In hypoxic K562 cells, we also observed a significant loss of overall Pol II signal intensity
at Pol II+ G4+ promoters (p < 0.05; 1348/8307 down, 16.2%; Fig. 2f), with Pol II loss occur-
ring almost entirely at sites where G4s were diminished (Additional file 1: Fig. S2E). These
findings are exemplified by genome browser views in Fig. 2g. Conversely, there was negli-
gible Pol II loss at Pol II+ G4− promoters (Additional file 1: Fig. S2F). Thus, chromatin
compaction causes a loss of many promoter G4s with concomitant loss of Pol II.
G4 stabilisation by small molecules counteracts G4 and Pol II loss in hypoxia
To directly assay if G4 stabilisation impacts G4 formation in hypoxia, we visualised nu-
clear G4 foci [30] using U2OS cells since K562 cells were not amenable to G4 imaging.
Fig. 2 Chromatin compaction diminishes promoter G4 folding. a Graphical representation of experimental
design examining G4s, transcription and chromatin compaction induced by hypoxia. b Western blotting for
HIF1α from K562 cells cultured under normoxic or hypoxic conditions. ß-actin provides the loading control. c
Chromatin accessibility at promoters under normoxic conditions. Top panel, metagene plot for the median of
the normalised ATAC signal (3 biological replicates) centred at the TSS under normoxic conditions. Green,
promoters of active genes with a G4 (Pol II+ G4+); blue, active genes without a promoter G4 (Pol II+ G4−). Bottom
panel, data plotted for individual loci and represented by heatmaps. d–f MA plots showing fold change in ATAC-
seq signal (d), G4 ChIP-seq signal (e) and Pol II ChIP-seq signal (f) following hypoxia at active promoters with a
G4 (Pol II+ G4+). Blue and red, sites with significantly reduced or increase signal respectively (p < 0.05). CPM read
count per million. g Genomic view of EIF4E-BP1 and KCTD5 exemplify genes that significantly change in ATAC-
seq (green), Pol II ChIP-seq (black) and G4 ChIP-seq peaks (yellow). Tracks compare peaks between hypoxia and
normoxia. Genomic coordinates indicate track range and the signal is quantified as counts per million (CPM). In
all panels normoxia refers to cells cultured in 21% O2 and hypoxia refers to cells exposed to 1% O2 for 1 h
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pyPDS, a PDS analogue with improved lipophilicity (clogP PDS 2.35, pyPDS 4.79, cal-
culated using MarvinSketch version 20.19.0), was used to stabilise G4s [31, 32] (Add-
itional file 1: Fig. S4A). In hypoxia without pyPDS, global G4 signal intensity and G4
foci numbers were reduced (p < 0.0001, Additional file 1: Fig. S5). However, with pyPDS
addition, fewer G4s were lost (p < 0.0001), showing that G4 stabilisation protects G4s
from unfolding in hypoxia.
Given that chromatin compaction leads to a loss of Pol II at sites where promoter
G4s are diminished, we evaluated whether the induced persistence of G4 structures in
hypoxia caused by G4 stabilisation could cause retention of RNA Pol II binding
(Fig. 3a). Using ATAC-seq with K562 cells, we first confirmed that pyPDS treatment
did not appreciably alter chromatin accessibility in normoxia and that chromatin com-
paction still ensues under hypoxic conditions (Fig. 3b, Additional file 1: Fig. S4B). For
Fig. 3 G4 stabilisation in compacted chromatin retains promoter Pol II occupancy. a Graphical
representation of experimental design examining the consequences of G4 stabilisation by pyPDS on
chromatin compaction and Pol II occupancy. b Chromatin accessibility differences for promoters of active
genes with a G4 (Pol II+ G4+) under hypoxia for cells treated with DMSO or pyPDS. Top panel, metagene
plot of ATAC signal centred at the TSS showing the signal difference between DMSO- and pyPDS-treated
hypoxic cells. Bottom panel, data plotted for individual loci and represented by a heatmap plot. c Venn
diagram showing sites that have lost Pol II occupancy between normoxic and hypoxic cells treated with
DMSO and its overlap with Pol II sites lost on treatment with pyPDS in hypoxic conditions compared to
DMSO treatment in normoxic conditions. This shows that the majority of Pol II sites seen reduced in
hypoxia are retained by pyPDS. d Similar to panel b but for signal differences in Pol II occupancy. e
Genome browser view displaying examples of genes involved in chromatin biology (e.g. BRD4 and CBX1)
that show changes in chromatin accessibility (ATAC-seq, green) and Pol II occupancy (Pol II ChIP-seq, black)
for cells under normoxic (top), hypoxic (middle) or hypoxic conditions treated with pyPDS (bottom).
Genomic coordinates are indicated above and signal quantified as counts per million (CPM)
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Pol II+ G4+ promoters, we found that pyPDS treatment reduced the loss of Pol II by
10-fold in hypoxia compared to DMSO-treated cells (10.6% vs 1.2% respectively, p <
0.05; Fig. 3c, d; Additional file 1: Fig. S4C-D). These findings are exemplified by gen-
ome browser views for the promoters of the chromatin regulators BRD4 and CBX1
(Fig. 3e). Furthermore, no changes in Pol II were observed with pyPDS treatment in
normoxia (Additional file 1: Fig. S4E), or at non-G4-marked promoters in pyPDS-
treated hypoxic cells (Additional file 1: Fig. S4F). These results rule out non-specific
ligand-associated effects on Pol II recruitment. Thus, the induced persistence of a G4
structure, that would otherwise be lost during chromatin compaction, causes retention
of Pol II binding.
Discussion
Here, through the use of chemical intervention, we show that the process of active
transcription is not necessary for promoter G4 folding in cells (Fig. 4a, b). This suggests
that negative superhelicity and strand separation of the DNA double helix associated
with actively transiting RNA polymerase complexes is not necessary for G4 folding.
Instead, we find that changes in the chromatin environment are able to influence
how G4s fold. In particular, by reducing chromatin accessibility, we can disrupt pro-
moter G4s folding (Fig. 4c). The precise details of how G4s become unfolded during
chromatin compaction under hypoxia are not clear. G4s have been suggested to be lost
through abrogation of APE1 activity, a protein thought to drive G4 formation during
base excision repair [20]. Hypoxia is associated with activation of DNA damage re-
sponse [33], but importantly, we found no changes in APE1 protein levels during hyp-
oxia either in the absence or presence of pyPDS (Additional file 1: Fig. S4G). This
suggests that G4 loss during hypoxia is through an alternative mechanism.
We use acute hypoxia to achieve rapid chromatin compaction with a short treatment
time to circumvent non-specific or downstream effects on G4 formation. Endogenous
G4 structures are only observed in accessible chromatin, while chromatin relaxation by
histone deacetylation leads to increased G4 folding [5]. Recent imaging experiments in
neuronal cells have also demonstrated that G4 folding requires chromatin accessibility
[34]. While we cannot rule out unknown factors that might further influence G4
Fig. 4 Model showing an interaction between promoter G4s, Pol II and chromatin status. a Promoter G4
folding is seen in accessible promoter regions. Pol II is recruited to the G4 to promote transcription. b
Transcriptional inhibition does not cause loss of promoter G4 folding. c Chromatin compaction causes G4
unfolding and loss of Pol II binding. d Ligand-mediated G4 stabilisation (red star) can preserve promoter G4
folding under conditions of chromatin compaction, which in turn causes retention of Pol II
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formation in hypoxia, the most straightforward interpretation of the data is that chro-
matin compaction in acute hypoxia leads to G4 loss.
Concurrent with promoter G4 loss during chromatin compaction, we find that Pol II
occupancy is also lost at the same promoters. We observe that if we apply a G4-specifc
small molecule ligand to stabilise promoter G4s, Pol II loss is abrogated. Thus, pro-
moter G4s and Pol II occupancy are coupled. This experiment also demonstrates that
G4s can be manipulated to augment Pol II occupancy in an otherwise inhibitory chro-
matin environment (Fig. 4d). Pol II recruitment at promoter G4s might be mediated by
TF binding [8–10], though it is also possible that G4s interact directly with subunits of
RNA Pol II [35].
Conclusions
In conclusion, our findings directly demonstrate that it is chromatin status and not tran-
scription that is a primary determinant of promoter G4 folding in cells. Furthermore, pro-
moter G4 folding leads to the retention of RNA Pol II suggesting that G4s act as a site for
the recruitment of key components of the transcriptional machinery. Our findings thus
provide a possible mechanism for enhanced transcription of genes carrying a promoter
G4, as the G4 structure itself may be sufficient to direct transcription.
Methods
Cell culture
K562 cells (ATCC, CCL-243) were cultured in RPMI 1640 (Thermo Fisher, 21875-034)
supplemented with 10% of foetal bovine serum (FBS; Thermo Fisher, A3840402). U2OS
cells (ATCC, HTB-96) were cultured in DMEM (Thermo Fisher, 41966-029) supple-
mented with 10% of FBS. Cells were cultured at 37 °C in 21% O2 and 5% CO2 unless
stated otherwise. Cell line genotypes were certified by the supplier. Cells lines were
confirmed mycoplasma-free by RNA capture ELISA. For hypoxia treatment, cells were
incubated in 1% O2, 5% CO2 at 37 °C. 5,6-dichlorobenzimidazole 1-β-D-ribofuranoside
(DRB) (Sigma), triptolide (Sigma) and pyPDS [31, 32] were dissolved in DMSO and
used at a final concentration of 100 μM, 10 μM and 1 μM, respectively. For G4 stabilisa-
tion in hypoxia, cells were pre-treated with pyPDS for 1 h and exposed to 1% O2 in the
presence of pyPDS for 1 h.
Western blotting
Cells were washed twice with ice-cold PBS and lysed in Pierce® RIPA buffer (Thermo
Fisher, 89900) by sonatication using a Bioruptor (Diagenode). The following primary anti-
bodies were used for immunoblotting: RNA Pol II C-terminal domain (CTD) phospho
Ser2 (Active Motif, 61084), RNA Pol II CTD phospho Ser5 (Abcam, ab5131), RNA Pol II
CTD (Abcam, ab817), HIF 1α (BD Biosciences, 610958), β-Actin (CST, 4970 or Sigma,
A5441) and APE1 (Novus Biologicals, NB100-116). IRDye secondary antibodies (LiCor)
were used, and the blot was visualised using a LiCor Odessey CLx instrument.
Micrococcal nuclease (MNase) digestion
One million cells were washed in ice-cold PBS and incubated in lysis buffer (10 mM
Tris pH 8, 10 mM MgCl2, 0.5% NP-40, fresh protease inhibitors + 1 mM DTT) at 4 °C
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for 10 min. Nuclei were pelleted by centrifugation at 1400×g for 5 min at 4 °C and
washed once with lysis buffer. Samples were digested with 0.5 U MNase at 25 °C in di-
gestion buffer (15 mM Tris pH 7.5, 60 mM KCl, 15 mM NaCl, 250 mM Sucrose, 1 mM
CaCl2, fresh PIC + 1mM DTT) and the reaction stopped with an equal volume of
MNase stop solution (40 mM EDTA + 0.5% SDS). DNA fragments were purified using
QIAGEN MinElute kit. Equal amounts of DNA (300 ng) from each sample were then
loaded and resolved on 2% E-Gel EX precast agarose gels (Thermo Fisher, G800802).
G4 ChIP-Seq
G4 ChIP-Seq was performed with at least 3 biological replicates using the G4-specific
antibody BG4 as described previously [14]. For each biological replicate, three inde-
pendent technical replicates and matched inputs were sequenced (75 nt single-end) on
an Illumina NextSeq instrument.
RNA polymerase II (Pol II) ChIP-seq
RNA polymerase II (Pol II) ChIP-seq was performed essentially with 5 biological repli-
cates as previously described [36]. Fifteen micrograms of chromatin was immunopreci-
pitated overnight with 5 μg RNA Pol II antibody (Abcam, ab817) bound to protein A/G
sepharose (Thermo Fisher, 10002D). Sequencing libraries were prepared by using NEB-
Next® Ultra™ II DNA Library Prep Kit for Illumina (NEB, E7645) and sequenced (75 nt
single-end) on an Illumina NextSeq instrument.
ATAC-seq
ATAC-seq was performed essentially with 3 biological replicates as previously de-
scribed [37]. Briefly, 50,000 K562 cells were collected and incubated with transposase
Tn5 at 37 °C. After 1-h incubation, tagmented DNA samples were amplified using the
Nextera Index kit (Illumina, FC-121-1030). DNA fractions were size selected and puri-
fied using AMPure XP beads (Beckman Coulter, A63880) according to the manufac-
turer’s instruction. Libraries were sequenced in paired-end with 75-nt read length using
the Illumina NextSeq instrument.
Immunofluorescence staining
Immunofluorescence staining with BG4 was performed essentially as described previ-
ously [30]. Digital images were taken using a TCS SP5 confocal microscope (Leica) with
Zeiss Zen software and analysed with Icy [38]. One hundred to 200 nuclei were
counted per condition. Frequency distribution graphs were plotted using GraphPad
Prism (GraphPad Software Inc.).
Human reference genome and relative genomic annotation
Human genome hg38 was downloaded from UCSC (hgdownload.cse.ucsc.edu/goldenPath/
hg38/bigZips/hg38.fa.gz). Human annotations (gtf file) were downloaded from the Gene-
code project portal (ftp.ebi.ac.uk/pub/databases/gencode/Gencode_human/release_28/
gencode.v28.annotation.gtf.gz, Release 28 GRCh38.p12). Annotations for genomic regions
(i.e. exons, introns, intergenic regions, 3′UTR, 5′UTR and 58,381 promoters of all coding
and not coding genes defined as TSS ± 500 bp) were extracted from the gtf file.
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ATAC-seq data analysis
Fastq reads were trimmed from adapters using cutatapt [39] (cutadapt -a AGATCGGA
AGAGC -A AGATCGGAAGAG). Resulting reads were aligned to hg38 with bwa mem
-M -t 12. Bam files were generated by using samtools view -Sb -F780 -q 10 -L (ver: 1.8)
[40]. All libraries were sequenced twice and processed and aligned separately. Resulting
alignments were merged and sorted. Duplicates were marked by Picard MarkDuplicates
(ver: 2.20.3, http://broadinstitute.github.io/picard) and removed. Fragment size distribu-
tion was estimated using uniquely mapped reads bams with Picard CollectInsertSize-
Metric. To assess the amount of mitochondria contamination, reads mapping to chrM
were identified and counted directly from the alignment bam files. For each library, re-
gions with local accessibility were identified by calling peaks with macs2 with default
options and excluding chrM. For each experimental condition, peak regions observed
in 2 out the 3 biological replicates were selected as the consensus regions using bed-
tools multiIntersectBed (version 2.27.1) [41].
G4 ChIP-seq and Pol II ChIP-seq data analysis
Fastq reads were trimmed from adapters using cutadapt (-m 10 -q 20 -O 3 -a CTGT
CTCTTATACACATCT) and aligned to the human genome hg38 with bwa mem. Bam
files were generated from alignment with samtools view, and duplicated reads were
marked and removed using picard MarkDuplicates. The total number of unique reads
was quantified for each library. Regions with local enrichments were obtained by calling
peaks with macs2 for each individual pull-down library paired to the corresponding in-
put control. For G4 ChIP-seq experiments, consensus regions of each biological repli-
cate were obtained as those observed in 2 out of the 3 technical replicates
(multiIntersectBed). The consensus by the experimental case (across biological repli-
cates) was obtained by selecting regions reproducibly observed in at least 2 of the 3 bio-
logical replicates. For Pol II ChIP-seq experiments, the consensus regions in each
experimental condition were obtained as the regions observed in at least 3 of the 5 bio-
logical replicates.
For both types of ChIP-seq, genome-wide reads per million (RPM) G4 signal was ob-
tained by quantifying the read coverage across the genome and scaling it to a factor
that reflected the individual library size (deeptools bamCoverage [42]–scaleFactor,
where factor = 1,000,000/Lib_size). Similarity across individual libraries from all three
cell types was evaluated on RPM at consensus regions per experimental condition.
Whenever it is referred to G4 or Pol II signal in a specific experimental condition, indi-
vidual libraries of the same experimental condition were combined together by calcu-
lating the median RPM signal (across biological/technical replicates). G4 consensus
regions were compared to the accessible consensus regions (ATAC) observed in the
same experimental conditions and quantified in terms of percentage of overlaps; G4
consensus regions were compared to in vitro observed G4 quadruplex (G4-seq [43])
and quantified by evaluating the percentage of overlaps.
Characterisation of G4 fold-enrichments at sites of interests
Fold enrichments for G4s over random chance were evaluated at various sites of
interest whose genomic coordinates were stored into bed files. Fold enrichments
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were computed by using the Genomic Association Tester (GAT, https://gat.
readthedocs.io/en/latest/contents.html, 1000 randomizations), and the analysis was
restricted to the human whitelist. The analysis generated the number of overlaps
between the G4 consensus sites and the segments to query against (actual), and
the fold-enrichments were obtained after summarising results from randomisations.
Density plots of genomic signals at TSS
The metagene density signal profile at transcription start sites (TSSs) was produced
similarly for G4, Pol II and ATAC-seq data. After creating bed files with the set/s of re-
gions of interest, we employed the function computeMatrix from deeptools on BW files
containing RPM signals). Next, RPM signals were combined together by averaging rep-
licates of the same cell and then generating a new matrix of signals. The difference of
normalised summarised signals between two experimental conditions was obtained by
subtracting the matrix of normalised signal in one condition to the matrix of the other
condition under investigation. Heatmaps were produced using deeptools plotHeatmap
(options: --averageTypeSummaryPlot median). Metagene density signal profile plots
were obtained by plotting the average trend of the signal of interest (i.e. difference be-
tween two experimental cases).
Differential signal analysis
All differential binding signal analyses were carried out with the R package edgeR.
Initially, library size and read coverages at the regions of interest were computed.
Prior differential testing, the average cpm (counts per millions) signal was esti-
mated across all input libraries and a threshold value was defined as 2 times the
99th quantile of the average distribution of input cpm. Subsequently, regions for
which at least one pull-down library exceeded the threshold value previously de-
fined were kept for subsequent analysis. This step happened for each sequencing
assay independently and only for the case when input libraries were available (G4
ChIP-seq, Pol II ChIP-seq). A generalised linear model (glmLRT) with default pa-
rameters (negative binomial log-linear distribution of read counts) was used to as-
sess regions with a differential binding signal. For the differential test, batch
information, biological and technical (when present) replicates were incorporated in
the definition of the design matrix. The differential binding analysis compared pairs
of experimental conditions: hypoxia vs normoxia (G4 ChIP-seq, ATAC-seq, Pol II
ChIP-seq); all pairwise comparison among DMSO hypoxia, DMSO normoxia,
pyPDS hypoxia and pyPDS normoxia. Regions with differential signal were identi-
fied as those with p value ≤ 0.05. The regions of interest used to test the effects of
hypoxia plus pyPDS or hypoxia alone were defined as the G4 consensus regions
overlapping Pol II consensus regions in normoxia at promoters (TSS ± 500 bp). In
the case of DRB and TPL experiments, the regions used for the differential signal
analysis were obtained as the merge of the regions observed in treatment and con-
trol case for each experimental condition, respectively. To illustrate the outcome of
the differential analysis, Bland Altman (MA) plots showing the average CPM (x-
axis) versus the log-fold change (y-axis) obtained comparing the 2 conditions of
interest were used.
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